Detalhe da pesquisa
1.
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series.
Melanoma Res
; 32(6): 451-459, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164923
2.
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma.
Clin Transl Radiat Oncol
; 30: 95-99, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458597
3.
Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma.
Pigment Cell Melanoma Res
; 33(2): 358-365, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587511